Oral Immune-Related Adverse Events Associated with PD-1 Inhibitor Treatment: A Case Series
Oral Immune-Related Adverse Events Associated with PD-1 Inhibitor Treatment: A Case Series
About this item
Full title
Author / Creator
Publisher
Basel: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel: MDPI AG
Subjects
More information
Scope and Contents
Contents
Introduction: Immune Checkpoint Inhibitor (ICI) drugs have led to a revolution in the treatment of different forms of cancer, shifting the target of action from cancer cells to the patient’s immune system, enhancing their responses against the tumor itself. On the other hand, this mechanism can lead to responses against oneself, with the appearance...
Alternative Titles
Full title
Oral Immune-Related Adverse Events Associated with PD-1 Inhibitor Treatment: A Case Series
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_23e7004a856d4f4f96f84fba6134faa0
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_23e7004a856d4f4f96f84fba6134faa0
Other Identifiers
ISSN
2076-3417
E-ISSN
2076-3417
DOI
10.3390/app122412994
